methysergide has been researched along with Parkinson Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilbert, JC | 1 |
| Berde, B | 1 |
| Bergen, D; Goetz, C; Klawans, HL | 1 |
| Aguggia, M; Cantello, R; Delsedime, M; Gilli, M; Mutani, R; Rainero, I; Riccio, A | 1 |
| Greenberg, HS; Hirschorn, KA | 1 |
| Carvey, PM; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Goetz, CG; Klawans, HL | 1 |
| Klawans, HL; Ringel, SP | 1 |
| Tyler, HR | 1 |
2 review(s) available for methysergide and Parkinson Disease
| Article | Year |
|---|---|
Pharmacology of ergot alkaloids in clinical use.
Topics: Animals; Brain Diseases; Bromocriptine; Dihydroergotamine; Dihydroergotoxine; Dopamine Antagonists; Ergot Alkaloids; Ergotamine; Female; Humans; Methysergide; Migraine Disorders; Parkinson Disease; Pituitary Gland; Prolactin; Receptors, Adrenergic; Receptors, Dopamine; Uterus; Vasoconstriction | 1978 |
Advances in neurology.
Topics: Analgesics; Anticoagulants; Brain; Brain Neoplasms; Carbamazepine; Cerebrovascular Disorders; Contraceptives, Oral; Diazepam; Encephalitis; Headache; Humans; Intracranial Aneurysm; Methysergide; Multiple Sclerosis; Muscular Diseases; Neuralgia; Pain; Parkinson Disease; Seizures; Tic Disorders | 1968 |
1 trial(s) available for methysergide and Parkinson Disease
| Article | Year |
|---|---|
Analgesic action of methylphenidate on parkinsonian sensory symptoms. Mechanisms and pathophysiological implications.
Topics: Aged; Analgesics; Biogenic Amines; Biomechanical Phenomena; Humans; Male; Methylphenidate; Methysergide; Middle Aged; Palliative Care; Parkinson Disease; Premedication; Propranolol; Sensation | 1988 |
6 other study(ies) available for methysergide and Parkinson Disease
| Article | Year |
|---|---|
Diseases of the central nervous system. Pharmacological basis of treatment.
Topics: Amantadine; Analgesics, Opioid; Anticonvulsants; Blood-Brain Barrier; Central Nervous System Diseases; Cholinesterase Inhibitors; Edrophonium; Epilepsy; Headache; Humans; Levodopa; Methysergide; Migraine Disorders; Myasthenia Gravis; Parkinson Disease; Pyridostigmine Bromide; Serotonin Antagonists | 1975 |
Levodopa-induced myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Amantadine; Amphetamine; Animals; Benztropine; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; Levodopa; Male; Methysergide; Middle Aged; Movement Disorders; Myoclonus; Parkinson Disease; Propranolol; Serotonin; Serotonin Antagonists; Sleep; Trihexyphenidyl | 1975 |
Successful treatment of levodopa-induced myoclonus and levodopa withdrawal-induced neuroleptic malignant syndrome. A case report.
Topics: Aged; Cyproheptadine; Humans; Levodopa; Male; Methysergide; Myoclonus; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1988 |
Drug-induced myoclonus.
Topics: 5-Hydroxytryptophan; Anesthetics; Animals; Anti-Bacterial Agents; Antidepressive Agents; Bismuth; Carbidopa; Electroencephalography; Gasoline; Guinea Pigs; Humans; Hydrocarbons, Brominated; Imipramine; Levodopa; Methysergide; Models, Biological; Myoclonus; Parkinson Disease; Sleep | 1986 |
Letter: Myoclonus, methysergide, and serotonin.
Topics: 5-Hydroxytryptophan; Animals; Dihydroxyphenylalanine; Drug Antagonism; Guinea Pigs; Humans; Methysergide; Myoclonus; Parkinson Disease; Receptors, Adrenergic; Serotonin Antagonists | 1974 |
A clinical study of methysergide in Parkinsonism: evidence against a serotonergic mechanism.
Topics: Adult; Aged; Basal Ganglia; Corpus Striatum; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Hypothalamus; Male; Methysergide; Middle Aged; Parkinson Disease; Serotonin; Serotonin Antagonists; Tremor | 1973 |